Company Changes (1/03)
You may also be interested in...
No device-related warning letters were released by the US FDA the week of 19 January.
Following a €2.5m award from the European Commission’s EIC Accelerator Program, Paris based CorWave has become the first EU company to obtain EIC fund investment. The company is developing a new pulsatile LVAD.
The UK biotech is set for a NASDAQ launch which could propel it to its first commercial launch by 2022.